EP12.01. Long-term Survivors with EGFR Positive Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors: A Combined Canadian Cohort - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Heather Halperin
Meta Tag
Speaker Heather Halperin
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
long-term survivors
EGFR positive non-small cell lung cancer
tyrosine kinase inhibitors
clinical characteristics
de novo advanced EGFRmut NSCLC
1st/2nd generation EGFR-TKI
Alberta Glans-Look Lung Cancer Research Database
Princess Margaret Cancer Centre
overall survival
Powered By